This transcript has been edited for clarity. Matthew A. Sparks, MD: I'm Dr Matthew Sparks, and welcome to Medscape's InDiscussion podcast series on chronic kidney disease. Today we'll be discussing ...

A new study found that people with systemic lupus erythematosus (SLE) may face a significantly higher risk of developing chronic kidney disease (CKD), cardiovascular complications and premature death, ...

AJMC ®: What measures can be taken to enhance comprehensive screening efforts for the early diagnosis of lupus nephritis in patients who have systemic lupus erythematosus? How do you screen for lupus ...

Early ASCVD screening at lupus nephritis diagnosis and annually thereafter are among the recommendations to mitigate risk. A ...

In reflecting on the American College of Rheumatology conference, Dr Maureen McMahon describes the impact of new guidelines on early diagnosis in systemic lupus erythematosus (SLE) and lupus nephritis ...

Panelists discuss the goals of therapy for lupus nephritis (LN), emphasizing the urgency of treatment to prevent renal flares and the consequences of untreated LN, as well as strategies for increasing ...

A new study found an association between health insurance status and long-term, adverse outcomes in people with systemic lupus erythematosus (SLE) and lupus nephritis (LN). Structural, individual, and ...

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by ...

Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic ...

New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare ...